PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.

Quarter-by-quarter ownership
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,612
+363.2%
93,711
+2642.5%
0.00%
+100.0%
Q2 2023$348
+11.9%
3,4170.0%0.00%0.0%
Q1 2023$311
+139.2%
3,4170.0%0.00%
+100.0%
Q4 2022$130
-99.8%
3,4170.0%0.00%
Q3 2022$86,000
-17.3%
3,4170.0%0.00%
-100.0%
Q2 2022$104,000
-7.1%
3,4170.0%0.00%0.0%
Q1 2022$112,000
+24.4%
3,4170.0%0.00%
Q4 2021$90,000
-73.8%
3,4170.0%0.00%
-100.0%
Q3 2021$344,000
-28.9%
3,4170.0%0.00%0.0%
Q2 2021$484,000
+41.9%
3,4170.0%0.00%0.0%
Q1 2021$341,000
-19.2%
3,4170.0%0.00%0.0%
Q4 2020$422,000
+26.7%
3,4170.0%0.00%0.0%
Q3 2020$333,000
-37.5%
3,4170.0%0.00%
-33.3%
Q2 2020$533,000
+8.1%
3,4170.0%0.00%0.0%
Q1 2020$493,000
-29.5%
3,4170.0%0.00%
-25.0%
Q4 2019$699,000
+119.1%
3,417
-14.0%
0.00%
+100.0%
Q3 2019$319,000
-14.9%
3,9750.0%0.00%0.0%
Q2 2019$375,0003,9750.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders